Authors


LOUISE DE SOUZA, PHARMD

Latest:

Long-Acting Anti-MRSA Agents: One Dose to Cure?

A review of the current literature and future directions.


Brian Dunleavy

Latest:

New Technology Enables Differentiation of Bacterial and Viral Infections

It can help inform appropriate antibiotic prescribing, but likely would only form part of testing protocol, experts say.


Aniruddha (Anu) Hazra, MD

Latest:

Living and Aging With HIV: Recognition and Management of Common Prescribing Pitfalls

With advancements in antiretroviral therapy, people with HIV are now living longer and developing age-related chronic conditions.



Sarah E. Rowan, MD

Latest:

With the Opioid Epidemic, Communities See Dramatic Increases in Infectious Diseases

Rising incidence of viral and bacterial infections has accompanied the opioid crisis, but it also presents new opportunities for multidisciplinary treatment and preventive care.


Kristen Zeitler, BS, PharmD, BCPS

Latest:

Antibiotic Stewardship Programs in the Hospital Setting: Guidance from the Centers for Disease Control and Prevention

While antibiotics serve a meaningful purpose in treating infections, appropriate use of these agents is needed in order to minimize adverse events.


Lily Rotman, MD

Latest:

New and Pipeline Antiretroviral Agents for the Treatment of HIV-1 Infection

This article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.


Sarah Anwar

Latest:

Will Brazil's Next Epidemic Come from Another Mosquito-Borne Virus?

As researchers discover Chikungunya-carrying mosquitoes in Brazil, a new study analyzes the impact of the Zika virus on the area.


Michael P. Veve, PharmD, MPH

Latest:

Using IL-6 Inhibitors to Treat COVID-19

Use of an IL-6 inhibitor has the potential to prevent the cytokine storm caused by severe COVID-19 infection.


Laura Joszt

Latest:

Clinicians Only Using New Antibiotics in Quarter of CRE Infection Cases, New Study Finds

As a growing number of infections become resistant to antibiotic medications, it is becoming crucially important that providers not only practice antibiotic stewardship but also use effective antibiotics when they are needed.


Karlyn D. Beer, PhD, MS

Latest:

Four Fungal Horsemen: Emerging Trends in Fungal Disease Epidemiology

New public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.


JASON KINDRACHUK, PHD

Latest:

What the 2018 DRC Ebola Epidemic Taught Us About Outbreak Response and Experimental Countermeasures

How has treating infections changed with the availability of experimental vaccines and therapeutics, and how can we apply this to COVID-19 today?



WILLIAM C. PACE, MD

Latest:

A Peculiar Finding in an Unfamiliar Patient

A rare metallo-ß-lactamase makes its way into the United States via an 84-year-old patient.


KALIN M. CLIFFORD, PHARMD, BCPS, BCGP

Latest:

Successful Stewardship Strategies in Long-Term Care Facilities

One successful model takes an engineering approach to patient safety outcomes focusing on work system improvements.


M. May Zhang

Latest:

ART Adherence in Transgender and Gender Nonconforming People

A recent study published in Transgender Health analyzed transgender and gender-nonconforming ART adherence based on the US Trans Survey, the largest survey of TGNC people in the United States.


Marilyn Bulloch, PharmD, BCPS

Latest:

Fighting Flu: Managing and Preventing Influenza with Antivirals

Taking into account the severity of this flu season, it is important that health care providers understand and choose the best treatment option for each patient.


VIKTORIJA O. BARR, PHARMD, BCPS-AQ ID

Latest:

Is Greater BSA Use for Sepsis, Bacteremia Affecting HO-CDIs?

An examination of broad-spectrum antibiotic use in this patient population is essential for developing strategies to mitigate the risk of these infections.


Amber F. Ladak, PharmD

Latest:

Antiretroviral Stewardship: The Time is Now

In this narrative review of studies evaluating antiretroviral stewardship programs (ARVSPs), we propose core elements for ARVSPs that are based on published evidence, clinical experience, and adapted from antimicrobial stewardship programs.


Gregory Maslak, MD

Latest:

A Case of CNS Nocardia farcinica Presenting as Aphasia in an Immunocompetent Host

Quick recognition is key to early initiation of treatment and long-term survival.


Jennifer Nessel

Latest:

Rocky Mountain Spotted Fever Risk Factors Examined

The survey of households found that although 80% of residents had heard of Rocky Mountain spotted fever, less than half used pesticides to prevent the presence of ticks.


Charles A. Peloquin, PharmD

Latest:

Individualized Beta-Lactam Therapy and Monitoring

Elevated beta-lactam concentrations have been associated with neurotoxic adverse effects, including seizures and mental status changes.


Jaime Rosenberg

Latest:

Estimating HIV Screening Incidence Among US Citizens

Investigators used national electronic health record data to determine the proportion of American adults who have been tested for HIV.


Payal Patel, MD, MPH

Latest:

Coffee, Donuts, and Antimicrobial Stewardship

Targeting stewardship interventions to the morning hours may have a greater impact than afternoons and nights.


Grant M. Gallager

Latest:

Systematic Review Highlights Hydroxychloroquine Ambiguities

Investigators sought to summarize evidence about the benefits and harms of hydroxychloroquine and chloroquine as treatments or prophylaxis of COVID-19.


David Cluck, PharmD, BCPS, AAHIVP

Latest:

Guidelines to Caring for Patients With Sepsis: Promise or Progress?

Care continues to improve; however, drug-resistant pathogens and a lack of new agents to treat these infections remain a constant challenge.


George Sakoulas, MD

Latest:

Key Takeaways on Managing ABSSSI

George Sakoulas, MD, shares key takeaways on soft tissue infections from ID week 2023.


Laurie Toich

Latest:

Teva Pharmaceuticals Announces Launch of Generic HIV Drug

Teva Pharmaceuticals announces an exclusive launch of a generic version of atazanavir capsules for the treatment of HIV.


Rachel Britt, PharmD*

Latest:

Entering the Ring: Oral Vancomycin Versus Metronidazole for C difficile Infection and the Risk of Vancomycin-Resistant Enterococcus

In 2017, a guideline update stripped metronidazole of its first-line therapy designation and crowned oral vancomycin as initial therapy for all C difficile infection cases.


Alexander R. Evens, DO

Latest:

Integrating Order Sets Into Antimicrobial Stewardship Strategies

Since its implementation in December 2016, use of a ceftolozane-tazobactam order set at Marin General Hospital has advanced antimicrobial stewardship efforts.

© 2024 MJH Life Sciences

All rights reserved.